Anzeige
Mehr »
Mittwoch, 27.08.2025 - Börsentäglich über 12.000 News
Patentschutz bis in die 2040er - Biotech-Geheimtipp vor möglichem Fast-Track-Durchbruch in den USA!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU6V | ISIN: US1897631057 | Ticker-Symbol: C97
Tradegate
25.08.25 | 21:40
0,268 Euro
-0,74 % -0,002
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CO-DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
CO-DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,2800,29219:02
0,2800,29218:58

Aktuelle News zur CO-DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
19.08.Co-Diagnostics stock rating reiterated as Neutral by H.C. Wainwright3
15.08.Co-Diagnostics outlines clinical trial timeline and targets mid-2026 commercialization for PCR platform18
14.08.Co-Diagnostics GAAP EPS of -$0.23 beats by $0.02, revenue of $0.16M misses by $0.14M3
14.08.Co-Diagnostics, Inc. - 10-Q, Quarterly Report3
14.08.Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results434SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development...
► Artikel lesen
11.07.Co-Diagnostics, Inc. - 8-K, Current Report1
CO-DIAGNOSTICS Aktie jetzt für 0€ handeln
29.05.Co-Diagnostics, Inc. - 8-K, Current Report1
08.05.Co-Diagnostics GAAP EPS of -$0.24 beats by $0.03, revenue of $0.05M misses by $0.14M7
08.05.Co-Diagnostics, Inc. - 10-Q, Quarterly Report1
07.05.Co-Diagnostics Q1 2025 Earnings Preview2
07.05.Examining the Future: Co-Diagnostics' Earnings Outlook9
28.04.Co-Diagnostics, Inc. - 8-K, Current Report1
27.03.Co-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa10
27.03.Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results500SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the...
► Artikel lesen
27.03.Co-Diagnostics, Inc. - 10-K, Annual Report2
27.03.Co-Diagnostics, Inc. - 8-K, Current Report2
26.03.Uncovering Potential: Co-Diagnostics' Earnings Preview4
21.02.Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance264The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/...
► Artikel lesen
07.11.24Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results252SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1